[Lymphoblastic leukemia and immunological markers].
Acute lymphoblastic leukemia (ALL) is a heterogeneous entity that can be subcategorized on the basis of morphologic aspects, membrane antigens, caryotypic analysis and enzymatic content of the blast cells. Subgroups corresponding to T cells, Band pre-B cells, and non T non B lymphocytes derivations can be defined by immunologic markers. These studies ease the diagnosis and characterisation of ALL, perhaps their treatment, and enhance understanding of the disease.
Ifrah
N
N
Service de Médecine D, C. H. U. d'Angers.
Perrot
J Y
JY
Marie
J P
JP
Boasson
M
M
Zittoun
R
R
D000943:Antigens, Differentiation / Q000032:analysis*; D001402:B-Lymphocytes / Q000276:immunology*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000145:classification / Q000276:immunology / Q000473:pathology; D008221:Lymphoid Tissue / Q000033:anatomy & histology / Q000276:immunology; D010641:Phenotype; D011379:Prognosis; D013601:T-Lymphocytes / Q000276:immunology*
D000943:Antigens, Differentiation
Leucémies aiguës lymphoblastiques et marqueurs immunologiques.